Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease-Reference-Cited by-同舟云学术

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

Published:2019-11-11 Issue:12 Volume:11 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Palmqvist Sebastian¹²^ORCID,Insel Philip S¹³,Stomrud Erik¹⁴,Janelidze Shorena¹,Zetterberg Henrik⁵⁶⁷⁸,Brix Britta⁹,Eichenlaub Udo¹⁰,Dage Jeffrey L¹¹,Chai Xiyun¹¹,Blennow Kaj⁵⁶,Mattsson Niklas¹²¹²^ORCID,Hansson Oskar¹⁴^ORCID

Affiliation:

1. Clinical Memory Research Unit Department of Clinical Sciences Lund University Lund Sweden

2. Department of Neurology Skåne University Hospital Lund Sweden

3. Department of Psychiatry University of California, San Francisco San Francisco CA USA

4. Memory Clinic Skåne University Hospital Malmö Sweden

5. Department of Psychiatry and Neurochemistry The Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

6. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

7. Department of Neurodegenerative Disease UCL Institute of Neurology, Queen Square London UK

8. UK Dementia Research Institute at UCL London UK

9. Euroimmun AG Lübeck Germany

10. Roche Diagnostics GmbH Penzberg Germany

11. Eli Lilly and Company Indianapolis IN USA

12. Wallenberg Center for Molecular Medicine Lund University Lund Sweden

Funder

H2020 European Research Council

Vetenskapsrådet

Knut och Alice Wallenbergs Stiftelse

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201911170

Reference48 articles.

1. mixtools: AnRPackage for Analyzing Finite Mixture Models

2. Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

3. Subthreshold amyloid and its biological and clinical meaning

4. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

5. The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Pressure Variability and Plasma Alzheimer’s Disease Biomarkers in the SPRINT Trial;Journal of Alzheimer's Disease;2024-01-31

2. Protein Misfolding in Pregnancy: Current Insights, Potential Mechanisms, and Implications for the Pathogenesis of Preeclampsia;Molecules;2024-01-26

3. Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer’s disease;Scientific Reports;2024-01-05

4. Alzheimer’s disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling;The Innovation;2024-01

5. Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01